¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"activated partial prothrombin time"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • partial denture
    ºÎºÐÀÇÄ¡, ±¹¼ÒÀÇÄ¡
  • partial gastrectomy
    ºÎºÐÀ§ÀýÁ¦(¼ú)
  • partial hospitalization
    ºÎºÐÀÔ¿ø
  • partial mole
    ºÎºÐÆ÷»ó±âÅÂ, ºÎºÐÆ÷µµ¼ÛÀ̱âÅÂ
  • partial order
    ºÎºÐ¼øÀ§, ¹Ý¼øÀ§
  • partial ossicular replacement prosthesis
    ±Ó¼Ó»ÀºÎºÐ´ëÄ¡¹°, À̼ҰñºÎºÐ´ëÄ¡¹°
  • partial pressure
    ºÐ¾Ð
  • partial rebreathing
    ºÎºÐÀçÈ£Èí
  • partial seizure
    ºÎºÐ¹ßÀÛ
  • partial sex linkage
    ºÎºÐ¹Ý¼º(Ý»ÝÂÚáàõ)
  • partial thickness graft
    ºÎºÐÃþÀÌ½ÄÆí, ºÎºÐÃþÀ̽ļú
  • partial transposition
    ºÎºÐÀüÀ§, ºÎºÐÀÚ¸®¹Ù²Þ(Áõ)
  • partial volume effect
    ºÎºÐ¿ëÀûÈ¿°ú
  • simple partial seizure
    ´Ü¼øºÎºÐ¹ßÀÛ
  • arm-to-retina circulation time
    ÆÈ¸Á¸·¼øÈ¯½Ã°£
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • scrub time
    ¼Õ¾Ä´Â½Ã°£
  • survival time
    »ýÁ¸±â°£
  • thrombin time
    Æ®·Òºó½Ã°£
  • transit time
    ÀüÀ̽ð£, Åë°ú½Ã°£
  • voiding time
    ¹è´¢½Ã°£
  • real time ultrasonography
    ½Ç½ÃÃÊÀ½ÆÄÃÔ¿µ¼ú
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • partial hospital
    ºÎºÐº´¿ø
  • partial hospitalization
    ºÎºÐÀÔ¿ø
  • partial body irradiation
    ºÎºÐ½ÅüÁ¶»ç
  • partial sex linkage
    ºÎºÐ¹Ý¼º
  • partial order
    ¹Ý¼ø¼­, ºÎºÐ¼ø¼­
  • partial
    ºÎºÐ-
  • partial pressure
    ºÐ¾Ð
  • partial rebreathing
    ºÎºÐÀçÈ£Èí
  • partial seizure
    ºÎºÐ¹ßÀÛ
  • partial transposition
    ºÎºÐÀüÀ§, ºÎºÐÀÚ¸®¹Ù²ñÁõ
  • partial valency
    ºÎºÐ¿øÀÚ°¡
  • partial zygote
    ºÎºÐÁ¢ÇÕü
  • partial ossicular replacement prosthesis
    ±Ó¼Ó»ÀºÎºÐ´ëÄ¡¹°, À̼ҰñºÎºÐ´ëÄ¡¹°
  • partial saturation spin echo sequence
    ºÎºÐÆ÷È­½ºÇɸ޾Ƹ®¿¬¼â
  • simple partial seizure
    ´Ü¼øºÎºÐ¹ßÀÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • AUC : area under the concentration-time curve
    Ç÷Áß(¾à¹°)³óµµ°î¼±ÇϸéÀû.
  • BUT->breakup time of tear film
    ´«¹°¸·ÆÄ±«½Ã°£, ´©¾×¸·ÆÄ±«½Ã°£
  • Conduction time
    Àüµµ½Ã°£
  • MTT=£¾mean tidal time
    Æò±Õ¼øÈ¯½Ã°£.
  • Russells viper venom time
    ·¯¼¿¹ÙÀÌÆÛº£³ð½Ã°£
  • T.G.C (time gain compensation)
    ½Ã°£ (ãÁÊà) °ÔÀÎ º¸»ó (ÜÍßÁ), °Å¸®(±íÀÌ) °ÔÀÎ º¸»ó
  • T.G.C (time gain compensation)
    ½Ã°£ °ÔÀÎ º¸»ó
  • T1 relaxation time
    T1 ÀÌ¿Ï ½Ã°£
  • T2 (spin spin) relaxation time
    T2(½ºÇɽºÇÉ) À̿Ͻð£
  • T2 relaxation time
    T2 ÀÌ¿Ï ½Ã°£
  • TM scan(Time motion)
    ½Ã°£ ¿îµ¿ ¹æ½Ä
  • TM-scan(Time motion)
    ½Ã°£ ¿îµ¿ ¹æ½Ä (ãÁÊà ê¡ÔÑ Û°ãÒ)
  • TOF (time of flight)
    È帧 ½Ã°£ TOF(Ƽ¿À¿¡ÇÁ), À¯Ã¼ ¼Óµµ °­?
  • acquisition time
    ȹµæ ½Ã°£
  • appearance time
    ÃâÇö½Ã°£(õóúÞãÁÊà) ¼øÈ¯(âàü») .
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • lymphokine-activated killer cell
    ¸²Æ÷Ų-Ȱ¼º »ì¼¼Æ÷
  • magnetically activated implant
    ÀÚ±â Ȱ¼º ÀÌ½ÄÆí
  • mitogen-activated protein kinase
    ¹ÌÅä°Õ Ȱ¼º ´Ü¹é ±Í³ªÁ¦(¡­ üÀàõ Ó±ÛÜ ¡­ )
  • benign partial epilepsy of childhood
    ¼Ò¾Æ±â ¾ç¼ººÎºÐ°£Áú
  • complex partial seizure
    º¹ÇպκйßÀÛ(ÜÜùêÝ»ÝÂÛ¡íÂ)
  • extracorporeal partial nephrectomy
    ü¿Ü ºÎºÐ½ÅÀûÃâ¼ú
  • free end saddle partial denture
    À¯¸®´Ü±¹ºÎÀÇÄ¡.
  • hepatoduodenal fold (partial)
    °£»ùâÀÚÁÖ¸§(ºÎºÐ)
  • horizontal partial laryngectomy
    ¼öÆòºÎºÐÈĵÎÀûÃâ¼ú
  • lipodystrophy, partial
    ºÎºÐÁö¹æÀÌ¿µ¾çÁõ.
  • oblique vein (partial)
    ºøÁ¤¸Æ(ºÎºÐ)
  • oxygen partial pressure
    »ê¼ÒºÐ¾Ð(ß«áÈ ÝÂäâ).
  • partial abortion
    ºÎºÐÀû À¯»ê(Ý»ÝÂîÜêüß§).
  • partial adjustment
    ºÎºÐÀû ÀûÀÀ.
  • partial agglutination
    ºÎºÐÀû ÀÀÁý(¡­ëêó¢).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • generation time
    ¼¼´ë ½Ã°£(á¦ÓÛãÁÊà)
  • generation-time hypothesis
    ¼¼´ë ½Ã°£ ¼³(á¦ÓÛãÁÊààã)
  • half-reaction time
    ¹Ý¹ÝÀÀ ½Ã°£(ÚâÚãëëãÁÊà)
  • half-time
    ¹Ý ½Ã°£(ÚâãÁÊà)
  • high-temperature-short-time method
    °í¿Â ´Ü½Ã°£¹ý(ÍÔè®Ó­ãÁÊàÛö)
  • mean generation time
    Æò±Õ¼¼´ë±â°£(øÁгá¦ÓáÑ¢Êà)
  • recovery time
    ȸ¼ö ½Ã°£(üÞâ¥ãÁÊà)
  • relaxation time
    ÀÌ¿Ï ½Ã°£(ì¬èÐãÁÊà)
  • residence time
    µ¿°Å ½Ã°£(ÔÒËÜãÁÊà)
  • resolving time
    "ºÐ¸®½Ã°£, ÇØ»ó½Ã°£"
  • retention time
    ¸Ó¹«¸§ ½Ã°£
  • rotational relaxation time
    ȸÀü À̿Ͻð£(üÞï®ì¬èÐãÁÊà)
  • thermal death time
    ¿­»ç½Ã°£ (æðÞÝãÁÊà)
  • time constant
    ½Ã°£»ó¼ö (ãÁÊàßÈâ¦)
  • time constant of a reaction
    ¹ÝÀÀ ½Ã°£»ó¼ö (ÚãëëãÁÊàßÈâ¦)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • intercostal real-time scanning
    ´Á°£ ½Ç½Ã°£½ºÄµ
  • inversion time
    ¿ªÀü½Ã°£
  • longitudinal relaxation time
    Á¾ÃàÀ̿Ͻð£
  • mean survival time
    Æò±Õ»ýÁ¸½Ã°£
  • polymerizing time
    ±»´Â½Ã°£, ÁßÇսð£
  • pulmonary circulation time
    Æó¼øÈ¯½Ã°£
  • real time
    ½Ç½Ã°£, Áï½Ã
  • real time acquisition
    ½Ç½Ã°£È¹µæ
  • real time display
    ½Ç½Ã°£Ç¥½Ã
  • real time image
    ½Ç½Ã°£¿µ»ó
  • real time imaging
    ½Ç½Ã°£¿µ»ó±â¹ý
  • real time study
    ½Ç½Ã°£°Ë»ç
  • real time system
    ½Ç½Ã°£Ã¼°è
  • recovery time
    ȸº¹±â°£, ȸº¹ ½Ã°£
  • relaxation time
    À̿Ͻð£
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
MAP malignant atrophic papulosis; mandibular angle plane; maturation-activated protein; maximal aerobic ...
ST esotropia; scala tympani; scaphotrapezoid; sclerotherapy; sedimentation time; semitendinosus; sensor...
TT tablet triturate; tactile tension; tendon transfer; test tube; testicular torsion; tetanus toxin; te...
PT   1) Prothrombin Time
  2) Physical Therapy; ¹°¸®¿ä¹ý
  3) Pulmonary...
PRTH-C prothrombin time control
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
PT prothrombin
P.C.A. prothrombin complex activity
ACT Activated Coagulation Time
TE time , expiratory time
APOLT Auxiliary partial orthotopic liver transplantation
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • partial oligodontia
    ºÎºÐÀû ¹«Ä¡Áõ
  • partial PACS
    ºÎºÐ ÆÑ½º
  • partial pressure
    ºÐ¾Ð
    °¡½º È¥ÇÕü¿¡ À־ °¢°¢ÀÇ °¡½º ¼ººÐÀÇ ¾Ð·Â.
  • partial saturation
    ºÎºÐ Æ÷È­
  • partial saturation state
    ºÎºÐ Æ÷È­ »óÅÂ
  • partial shell crown
    ±¹ºÎ ±Ý°ü
  • partial symptom
    ºÎÁõ»ó
  • partial veneer crowm
    ºÎºÐ ÀüÀå°ü
    º¸Åë ¼ø¸éÀº µ¤Áö ¾Ê°í ±× ¿Ü Ä¡°ü¸éÀ» µ¤´Â ¼öº¹¹°.
  • partial volume averaging
    ºÎºÐ ¿ëÀû Æò±ÕÈ­
  • partial volume imaging
    ºÎºÐ ¿ëÀû ¿µ»ó
  • reaction of partial identity
    ºÎºÐ ÀÏÄ¡ ¹ÝÀÀ
  • rotational path removable partial denture
    ȸÀü °æ·Î·Î ÀåÂøÇÏ´Â °¡Ã¶¼º ºÎºÐ»ó ÀÇÄ¡
  • tissue-borne partial denture
    Á¶Á÷ ÀÇÄ¡
  • acquisition time
    ȹµæ ½Ã°£
  • area under the concentration-time curve
    Ç÷Áß ³óµµ °î¼±ÇÏ ¸éÀû, Ç÷Áß ¾à¹° ³óµµ °î¼±ÇÏ ¸éÀû
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
caspase-activated deoxyribonuclease <enzyme> Degrades DNA during apoptosis, inhibited by icad (inhibitor of cad); a protein of 343 amino acids carrying a nuclear localization signal.
Registry number: EC 3.1.-
Synonym: cad enzyme, caspase-activated dnase
(26 Jun 1999)
ceramide-activated protein kinase <enzyme> Mw 97 kD; stimulation of kinase takes place during sphingomyelin pathway; has membrane-bound activity capable of phosphorylating a peptide derived from the sequence surrounding thr(699) of the epidermal growth factor receptor; has role in signal transduction for tumour necrosis factor
Registry number: EC 2.7.10.-
Synonym: cap kinase
(26 Jun 1999)
ceramide-activated protein phosphatase <enzyme> Belongs to the heterotrimeric subfamily of the pp2a group of serine-threonine protein phosphatases; involved in ceramide-mediated signal transduction; inhibited by okadaic acid
Registry number: EC 3.1.3.-
Synonym: ceramide-stimulated phosphatase, capp (enzyme)
(26 Jun 1999)
monocytes, activated killer Monocytes made cytotoxic by ex vivo incubation with cytokines, especially interferon-gamma. Akm cells are used for adoptive immunotherapy in cancer patients.
(12 Dec 1998)
platelet endothelial cell activated protease <enzyme> Degrades casein and fibrinogen; secreted by endothelial cells and activated in the extracellular medium by platelets; not inhibited by serine protease inhibitors, metalloproteinase inhibitors, or cystein protease inhibitors; pH optimum 7.5
Registry number: EC 3.4.99.-
Synonym: pecap
(26 Jun 1999)
DNA-activated protein kinase <enzyme> Nuclear serine-threonine protein kinase that phosphorylates DNA-binding proteins; may function in cell homeostasis
Registry number: EC 2.7.10.-
Synonym: DNA-pk, DNA-dependent protein serine-threonine kinase, DNA-dependent protein kinase, scid gene product, xrcc7 gene product
(26 Jun 1999)
immunologically activated cell An immunocyte that is in an elevated state of reactivity capable of carrying out an immune response, in contradistinction to an immunologically competent cell.
(05 Mar 2000)
thiol activated haemolysins Cytolytic bacterial exotoxins that act by binding to cholesterol in cell membranes and forming ring like complexes that act as pores. SH groups of these toxins must be in the reduced state for the toxin to function. Oxidation (to disulphide bridges) inactivates the toxin.
Examples: tetanolysin, streptolysin O, _ toxin, cereolysin.
(18 Nov 1997)
TNF-IL1-activated protein kinase <enzyme> Phosphorylates beta casein in vitro; not the same as casein kinase 1 and casein kinase 2; not activated by mitogens, celllular stresses or any other cytokines than il1 and tnf
Registry number: EC 2.7.1.-
Synonym: tip kinase, beta casein kinase
(26 Jun 1999)
Fas-activated serine-threonine kinase <enzyme> Phosphorylates tia-1 during fas-mediated apoptosis; contains proline-rich sh3-binding domains; mw 60-63 kD; genbank x86779
Registry number: EC 2.7.10.-
Synonym: fast kinase
(26 Jun 1999)
killer cells, lymphokine-activated Cytolytic lymphocytes with the unique capacity of killing natural killer (nk)-resistant fresh tumour cells. They are interleukin-2-activated nk cells that have no MHC (major histocompatibility complex) restriction or need for antigen stimulation. Lak cells are used for adoptive immunotherapy in cancer patients.
(12 Dec 1998)
fluorescence-activated cell sorter <technique> Flow cytometry is an emerging technique which holds great promise for the separation, classification and quantitation of blood cells and antibodies which affect blood cells.
Complex computerised instruments are used to pass a monocellular stream of cells, platelets or other microscopic particulate elements through a beam of laser light. The cells are categorised first by size and then computer analysed to sort the mixture of cellular elements into cell type by size.
Cells are labelled with fluorescent dye and then passed, in suspending medium, through a narrow dropping nozzle so that each cell is in a small droplet. A laser based detector system is used to excite fluorescence and droplets with positively fluorescent cells are given an electric charge. Charged and uncharged droplets are separated as they fall between charged plates and so collect in different tubes. The machine can be used either as an analytical tool, counting the number of labelled cells in a population or to separate the cells for subsequent growth of the selected population. Further sophistication can be built into the system by using a second laser system at right angles to the first to look at a second fluorescent label or to gauge cell size on the basis of light scatter. The great strength of the system is that it looks at large numbers of individual cells and makes possible the separation of populations with, for example: particular surface properties.
Tabulation of counted data in conjunction with size analysis enables determination of relative percentages of each specific cellular subset for which monoclonal antibody conjugates are utilised, even when the size of the cell is identical to other subset species.
Flow cytometry is a slightly imprecise but common term for the use of the Fluorescence-activated Cell Sorter (FACS).
(01 Dec 1998)
fluorescence-activated cell sorting <technique> A technique for separating and sorting cells marked with a fluorescent label based on how much they fluoresce at a particular wavelength.
(12 Jan 1998)
light-activated resin A resin which uses visible or ultraviolet light to excite a photoinitiator which interacts with an amine to form free radicals and initiate polymerization. Used mainly in restorative dentistry.
Synonym: light-activated resin.
(05 Mar 2000)
reaction of partial identity See: gel diffusion precipitin tests in two dimensions.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • time
    ½Ã°£,°èÀý,(º¹¼ö)½Ã´ë,-ȸ(¹è)
  • Central (Standard) Time
    ÁߺΠǥÁؽÃ(G.M.T.º¸´Ù 6½Ã°£ ´ÊÀ½)
  • Double Summer Time
    ÀÌÁß ¼­¸ÓŸÀÓ(Ç¥Áؽ𣺸´Ù 2½Ã°£ ºü¸§)
  • Eastern Standard time
    µ¿ºÎ Ç¥ÁؽÃ(ij³ª´Ù µ¿ºÎ,¹Ì±¹ µ¿ºÎ,¿À½ºÆ®·¹Àϸ®¾Æ µ¿¹«)
  • Father Time
    ½Ã°£ ÇҾƹöÁö
  • Greenwich (Mean(Civil)time
    ±×¸®´ÏÄ¡ Ç¥ÁؽÃ
  • Greenwich Mean Time
    ±×¸®´ÏÄ¡ Ç¥ÁؽÃ
  • Hawaii time
    =Hawaiian Standard TimeÇÏ¿ÍÀÌ Ç¥ÁؽÃ(GMEº¸´Ù 10½Ã°£ ´Ê°í ½Ã°£´ë´Â Alaska Time¿Í °°À½
  • Pacific(Standard) Time
    (¹Ì±¹ÀÇ) ÅÂÆò¾ç Ç¥ÁؽÃ
  • T-time
    ·ÎÄÏ ¹ß»ç ½Ã°£
  • Time Square
    New York ½ÃÀDZØÀå°¡
  • access time
    È£Ãâ½Ã°£(±â¾ï ÀåÄ¡¿¡ Á¤º¸¸¦ ±â·Ï,ÇØµ¶ÄÉ Çϱâ À§ÇÑ ½Ã°£);ÄÄÇ»ÅÍ¿ë¾î
  • apparent time
    (ÇØ½Ã°èµîÀÇ)žçÀÇ À§Ä¡·Î ÃøÁ¤Çϴ½ð£
  • atomic time clock
    ¿øÀÚ ¿¬´ë ½Ã°è
  • atonic time clock
    ¿øÀÚ¿¬´ë
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á